PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration

Elena Brin(Polaris (United States)), Wei He(Howard Hughes Medical Institute), Katherine Wu(Memorial Sloan Kettering Cancer Center), Zhaoming Dai, Hsin-Tze Lu(Polaris (United States)), Yudou He(Polaris (United States))
Oncotarget
July 26, 2017
Cited by 54


Related Papers